← Leaderboards
Carol Ann Sartorius
University Of Minnesota
$5,515,814
Attributed
$7,725,207
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $954.8K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,725,207 · 4
By mechanism
R01$7,420,906 · 3
R21$304,301 · 1
Top collaborators
- Carol Ann Lange5 shared
- Peter Kabos4 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Carol Ann Lange$17,870,830
- Christy Hagan$1,691,746
- Yasushi Nakagawa$2,923,605
- Thu Ha Truong$751,817
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeTumorHormonesEstrogen Receptor PositiveBreast Cancer CellProgesterone ReceptorsCellsWomanResistanceTumor GrowthMalignant Breast NeoplasmEndocrineHormone TherapyStem CellsEstrogensEstrogen ReceptorsTumor ProgressionGenesBindingMalignant NeoplasmsCell ProliferationRecurrenceSignal TransductionGenetic Transcription
Grant awards (21)
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2025 · GM · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$571,826
R01 · FY2024 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2024 · GM · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$589,881
R01 · FY2023 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2023 · GM · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$589,881
R01 · FY2022 · CA
Hormone Receptor Regulation of RNA Polymerase III$364,893
R01 · FY2022 · GM · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$597,064
R01 · FY2021 · CA
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$610,563
R01 · FY2020 · CA
Hormones and Stem Cells in Luminal Breast Cancer$328,691
R01 · FY2020 · CA · contact PI
Hormones and Stem Cells in Luminal Breast Cancer$318,829
R01 · FY2019 · CA · contact PI
Hormones and Stem Cells in Luminal Breast Cancer$328,691
R01 · FY2018 · CA · contact PI
Hormones and Stem Cells in Luminal Breast Cancer$328,691
R01 · FY2017 · CA · contact PI
Hormones and Stem Cells in Luminal Breast Cancer$328,691
R01 · FY2016 · CA · contact PI
Estrogen Receptor Composition of Disseminated Breast Cancer using Multiparametric Imaging$135,285
R21 · FY2016 · CA · contact PI
Hormones and Tumor Initiating Cells in Human Breast Cancers$278,301
R01 · FY2015 · CA · contact PI
Estrogen Receptor Composition of Disseminated Breast Cancer using Multiparametric Imaging$169,016
R21 · FY2015 · CA · contact PI
Hormones and Tumor Initiating Cells in Human Breast Cancers$270,162
R01 · FY2014 · CA · contact PI
Hormones and Tumor Initiating Cells in Human Breast Cancers$262,003
R01 · FY2013 · CA · contact PI
Hormones and Tumor Initiating Cells in Human Breast Cancers$278,931
R01 · FY2012 · CA · contact PI
Hormones and Tumor Initiating Cells in Human Breast Cancers$279,129
R01 · FY2011 · CA · contact PI